|
1
|
Capranico G, Kohn KW and Pommier Y: Local
sequence requirements for DNA cleavage by mammalian topoisomerase
II in the presence of doxorubicin. Nucleic Acids Res. 18:6611–6619.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Young RC, Ozols RF and Myers CE: The
anthracycline neoplastic drugs. N Engl J Med. 305:139–153. 1981.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thorn CF, Oshiro C, Marsh S,
Hernandez-Boussard T, McLeod H, Klein TE and Altman RB: Doxorubicin
pathways: Pharmacodynamics and adverse effects. Pharmacogenet
Genomics. 21:440–446. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Orhan B: Doxorubicin cardiotoxicity:
Growing importance. J Clin Oncol. 17:2294–2296. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Samuel L: Doxorubicin-induced
cardiotoxicity. Postgrad Med J. 71:3181995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pereira GC, Pereira SP, Pereira CV, Lumini
JA, Magalhães J, Ascensão A, Santos MS, Bjork JA, Moreno AJ,
Wallace KB, et al: Doxorubicin-induced cardiac, hepatic and renal
mitochondrial toxicity in an acute versus sub-chronic treatment
model. Biochim Biophys Acta. 1797 Supple:S812010. View Article : Google Scholar
|
|
7
|
Skladanowski A and Konopa J: Adriamycin
and daunomycin induce programmed cell death (apoptosis) in tumour
cells. Biochem Pharmacol. 46:375–382. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carter ME and Brunet A: FOXO transcription
factors. Curr Biol. 17:R113–R114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li M, Chiu JF, Mossman BT and Fukagawa NK:
Down-regulation of manganese-superoxide dismutase through
phosphorylation of FOXO3a by Akt in explanted vascular smooth
muscle cells from old rats. J Biol Chem. 281:40429–40439. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Y, Zhao Y, Liao W, Yang J, Wu L,
Zheng Z, Yu Y, Zhou W, Li L, Feng J, et al: Acetylation of FoxO1
activates Bim expression to induce apoptosis in response to histone
deacetylase inhibitor depsipeptide treatment. Neoplasia.
11:313–324. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin CH, Lin CC, Ting WJ, Pai PY, Kuo CH,
Ho TJ, Kuo WW, Chang CH, Huang CY and Lin WT: Resveratrol enhanced
FOXO3 phosphorylation via synergetic activation of SIRT1 and
PI3K/Akt signaling to improve the effects of exercise in elderly
rat hearts. Age (Dordr). 36:97052014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sharma G, Kar S, Palit S and Das PK:
18β-glycyrrhetinic acid induces apoptosis through modulation of
Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells. J Cell
Physiol. 227:1923–1931. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang PJ, Zhao J, Li HY, Man JH, He K,
Zhou T, Pan X, Li AL, Gong WL, Jin BF, et al: CUE domain containing
2 regulates degradation of progesterone receptor by
ubiquitin-proteasome. Embo J. 26:1831–1842. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Man J and Zhang X: CUEDC2: An emerging key
player in inflammation and tumorigenesis. Protein Cell. 2:699–703.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kotamraju S, Konorev EA, Joseph J and
Kalyanaraman B: Doxorubicin-induced apoptosis in endothelial cells
and cardiomyocytes is ameliorated by nitrone spin traps and
ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem.
275:33585–33592. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jian Z, Liang B, Pan X, Xu G, Guo SS, Li
T, Zhou T, Xiao YB and Li AL: CUEDC2 modulates cardiomyocyte
oxidative capacity by regulating GPX1 stability. EMBO Mol Med.
8:813–829. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Morakinyo A, Iranloye B and Adegoke O:
Calcium antagonists modulate oxidative stress and acrosomal
reaction in rat spermatozoa. Arch Med Sci. 7:613–618. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kalivendi SV, Konorev EA, Cunningham S,
Vanamala SK, Kaji EH, Joseph J and Kalyanaraman B: Doxorubicin
activates nuclear factor of activated T-lymphocytes and Fas ligand
transcription: Role of mitochondrial reactive oxygen species and
calcium. Biochem J. 389:527–539. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Konorev EA, Kennedy MC and Kalyanaraman B:
Cell-permeable superoxide dismutase and glutathione peroxidase
mimetics afford superior protection against doxorubicin-induced
cardiotoxicity: The role of reactive oxygen and nitrogen
intermediates. Arch Biochem Biophys. 368:421–428. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gomez-Cabrera MC, Sanchis-Gomar F,
Garcia-Valles R, Pareja-Galeano H, Gambini J, Borras C and Vina J:
Mitochondria as sources and targets of damage in cellular aging.
Clin Chem Lab Med. 50:1287–1295. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takasaki A, Hanyu H, Iwamoto T, Shirato K,
Izumi R, Toyota H, Mizuguchi J, Miyazawa K and Tomoda A:
Mitochondrial depolarization and apoptosis associated with
sustained activation of c-jun-N-terminal kinasein the human
multiple myeloma cell line U266 induced by
2-aminophenoxazine-3-one. Mol Med Rep. 2:199–203. 2009.PubMed/NCBI
|
|
23
|
Luo H, Yang Y, Duan J, Wu P, Jiang Q and
Xu C: PTEN-regulated AKT/FoxO3a/Bim signaling contributes to
reactive oxygen species-mediated apoptosis in selenite-treated
colorectal cancer cells. Cell Death Dis. 4:e4812013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiong H, Wang J, Guan H, Wu J, Xu R, Wang
M, Rong X, Huang K, Huang J, Liao Q, et al: SphK1 confers
resistance to apoptosis in gastric cancer cells by downregulating
Bim via stimulating Akt/FoxO3a signaling. Oncol Rep. 32:1369–1373.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arola OJ, Saraste A, Pulkki K, Kallajoki
M, Parvinen M and Voipio-Pulkki LM: Acute doxorubicin
cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res.
60:1789–1792. 2000.PubMed/NCBI
|
|
26
|
Kimes BW and Brandt BL: Properties of a
clonal muscle cell line from rat heart. Exp Cell Res. 98:367–381.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hescheler J, Meyer R, Plant S, Krautwurst
D, Rosenthal W and Schultz G: Morphological, biochemical, and
electrophysiological characterization of a clonal cell (H9c2) line
from rat heart. Circ Res. 69:1476–1486. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sipido KR and Marban E: L-type calcium
channels, potassium channels, and novel nonspecific cation channels
in a clonal muscle cell line derived from embryonic rat ventricle.
Circ Res. 69:1487–1499. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Watkins SJ, Borthwick GM and Arthur HM:
The H9C2 cell line and primary neonatal cardiomyocyte cells show
similar hypertrophic responses in vitro. In vitro Cell Dev Biol
Anim. 47:125–131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arstall MA, Sawyer DB, Fukazawa R and
Kelly RA: Cytokine-mediated apoptosis in cardiac myocytes: The role
of inducible nitric oxide synthase induction and peroxynitrite
generation. Circ Res. 85:829–840. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ly JD, Grubb DR and Lawen A: The
mitochondrial membrane potential (deltapsi(m)) in apoptosis; an
update. Apoptosis. 8:115–128. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sharifi AM, Mousavi SH and Jorjani M:
Effect of chronic lead exposure on pro-apoptotic Bax and
anti-apoptotic Bcl-2 protein expression in rat hippocampus in vivo.
Cell Mol Neurobiol. 30:769–774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhai D, Jin C, Huang Z, Satterthwait AC
and Reed JC: Differential regulation of Bax and Bak by
anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1. J Biol Chem.
283:9580–9586. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Salvesen GS: Caspases: Opening the boxes
and interpreting the arrows. Cell Death Differ. 9:3–5. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ghavami S, Hashemi M, Ande SR, Yeganeh B,
Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ and
Los M: Apoptosis and cancer: Mutations within caspase genes. J Med
Genet. 46:497–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang J, Liu X, Bhalla K, Kim CN, Ibrado
AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by
Bcl-2: Release of cytochrome c from mitochondria blocked. Science.
275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lam EW, Francis RE and Petkovic M: FOXO
transcription factors: Key regulators of cell fate. Biochem Soc
Trans. 34:722–726. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sunters A, de Mattos Fernández S, Stahl M,
Brosens JJ, Zoumpoulidou G, Saunders CA, Coffer PJ, Medema RH,
Coombes RC and Lam EW: FoxO3a transcriptional regulation of Bim
controls apoptosis in paclitaxel-treated breast cancer cell lines.
J Biol Chem. 278:49795–49805. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sunters A, Madureira PA, Pomeranz KM,
Aubert M, Brosens JJ, Cook SJ, Burgering BM, Coombes RC and Lam EW:
Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer
cells is mediated by c-Jun NH2-terminal kinase and Akt. Cancer Res.
66:212–220. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Concannon CG, Tuffy LP, Weisová P, Bonner
HP, Davila D, Bonner C, Devocelle MC, Strasser A, Ward MW and Prehn
JH: AMP kinase-mediated activation of the BH3-only protein Bim
couples energy depletion to stress-induced apoptosis. J Cell Biol.
189:83–94. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Samuel SM, Thirunavukkarasu M, Penumathsa
SV, Paul D and Maulik N: Akt/FOXO3a/SIRT1-mediated cardioprotection
by n-tyrosol against ischemic stress in rat in vivo model of
myocardial infarction: Switching gears toward survival and
longevity. J Agric Food Chem. 56:9692–9698. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang A, Guo C, Sun Y, Lu L, Wang Y, Wang
Q, Zhang Y, Zhang H, Wang L, Gu Y, et al: Overexpression of CUEDC2
predicts poor prognosis in ovarian serous carcinomas. J Cancer.
6:542–547. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sun L, Bai L, Lin G, Wang R, Liu Y, Cai J,
Guo Y, Zhu Z and Xie C: CUEDC2 down-regulation is associated with
tumor growth and poor prognosis in lung adenocarcinoma. Oncotarget.
6:20685–20696. 2015. View Article : Google Scholar : PubMed/NCBI
|
